Monitoring Highly Active Antiretroviral Therapy in HIV-infected Parents in Thailand
A Phase III, Randomized, Non-inferiority Trial Comparing the Standard Viral Load Based Antiretroviral Monitoring Strategy With a CD4 Based Monitoring Strategy Among Antiretroviral Naive Immunocompromised Adults in Thailand
Sponsor: Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
A PHASE3 clinical study on HIV Infections, this trial is completed. The trial is conducted by Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) and has accumulated 7 data snapshots since 2005. Infectious disease trials contribute critical data for public health response and treatment development.
Change History
7 versions recorded-
Sep 2025 — Present [monthly]
Completed PHASE3
-
Sep 2024 — Sep 2025 [monthly]
Completed PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE3
-
Jan 2022 — Jul 2024 [monthly]
Completed PHASE3
-
Jan 2021 — Jan 2022 [monthly]
Completed PHASE3
▶ Show 2 earlier versions
-
Jun 2018 — Jan 2021 [monthly]
Completed PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Completed PHASE3
First recorded
May 2005
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
- Harvard School of Public Health (HSPH)
- Institut de Recherche pour le Developpement
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
Bangkok, Thailand, Chacheongsao, Thailand, Hat Yai, Thailand, Khon Kaen, Thailand, Lampang, Thailand, Mae Chan, Thailand, Mae Rim, Thailand, Muang, Thailand, Muang, Chiangrai, Thailand, Muang, Chonburi, Thailand and 8 more location s